Grünenthal Group

Grünenthal is a global pharmaceutical company headquartered in Aachen, Germany, with a strong focus on pain management and related diseases. With a long history of developing innovative treatments for patients worldwide, the company operates a fully integrated model, covering the entire value chain from research and development to commercialization. Grünenthal is committed to its vision of a world free of pain, working to improve the lives of patients through a combination of research, strategic partnerships, and a robust global presence.

Grünenthal's commitment to responsible business practices is deeply embedded in its culture and strategy. The company strives to create a positive impact on society through its core business and beyond, guided by the principles of integrity, transparency, and ethical conduct. This commitment is reflected in the company's high ESG (Environmental, Social, and Governance) rating, placing it in the top 2% of the pharmaceuticals subindustry. Grünenthal also prioritizes sustainable practices, focusing on reducing its carbon footprint, saving energy and resources, and decreasing waste in its value chain.

Grünenthal offers various opportunities for flexible working arrangements. The company embraces a culture of work-life balance and empowers employees to choose options that best suit their individual needs and circumstances. This might include flexible working hours, remote work opportunities, or part-time arrangements, depending on the role and individual needs.

Grünenthal offers a comprehensive range of employee benefits, designed to support the well-being and development of their workforce. These benefits include competitive salaries, opportunities for professional growth, flexible working arrangements, comprehensive health insurance, and generous paid time off. The company also emphasizes a culture of inclusion and diversity, with initiatives promoting employee engagement, empowerment, and a positive work-life balance.

Grünenthal is a global leader in pain management and related diseases, dedicated to improving the lives of patients worldwide by bringing innovative treatments and state-of-the-art technologies to market. The company operates across the entire pharmaceutical value chain, from research and development to commercialization, with a commitment to achieving its vision of a World Free of Pain.

Grünenthal promotes a culture of collaboration, innovation, and patient-centricity. The company values entrepreneurship, integrity, and performance, encouraging its employees to be accountable, take smart risks, and always strive to improve patient lives. A strong emphasis is placed on respecting individuals, fostering a diverse and inclusive working environment, and ensuring transparency and ethical conduct in all actions and decisions.

Grünenthal is committed to fostering a culture of trust and inclusivity among employees, partners, and communities. They prioritize creating an environment where everyone feels valued and respected, encouraging diversity of thought and background. They actively work to increase diversity and inclusion within their workforce, offering equal opportunities for advancement and providing a platform for individuals to unleash their full potential.